Neuravi, a company out of Galway, Ireland, is releasing a new clot retrieval device for treating ischemic strokes. The minimally invasive EmboTrap is pushed across the site of the occlusion and expanded, with the flared wings grabbing onto the clot. It is then pulled back out along with the thrombus, clearing the vessel to allow blood to come through. The distal end has a complex shape that prevents bits of emboli from traveling away from the device and causing further brain damage.
The EmboTrap is already in regular use at the Karolinska University Hospital in Sweden, and clinicians have reported success using it in a study on 42 stroke patients.
From the announcement:
In the series, treatment with the device restored significant blood flow in 86 percent of patients, with the majority of patients recovering to be able to function independently.5
“The EmboTrap device represents a new wave in innovation for stent retrievers based on clot research and a fuller understanding of the underlying challenge,” said Eamon Brady, Neuravi’s CEO. “We are excited to announce our launch and pleased that, following the compelling clinical data published earlier this year, use of thrombectomy devices for endovascular stroke therapy is on the rise, which should save and improve the lives of many patients.”
The company’s ARISE II clinical trial will begin enrolling patients this year at select centers in the United States and Europe. The trial will gather data to support the use of the EmboTrap and to seek FDA approval.
Product page: Neuravi EmboTrap…